BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 26
• 27
• 28
• 31

• Business

  Cardiac Science Announces HeartCentrix(R) ECG Informatics Connectivity With Henry Schein, Inc. Medical Systems’ MicroMD(R) EMR 5.0 HeartCentrix(R) ECG

  December 21, 2007

   · 

  6 min read
• Business

  Baxter International, Inc. Fourth Quarter 2007 Financial Results Conference Call

  December 21, 2007

   · 

  1 min read
• Biotech Bay

  VaxGen, Inc. Common Stock Expected to Qualify for Quotation on OTC Bulletin Board Qualification

  December 21, 2007

   · 

  5 min read
• Biotech Bay

  VaxGen, Inc. Addresses MPM Claims in Letter to Stockholders Seeks to Correct the Record and Provide Accurate Information to Stockholders

  December 21, 2007

   · 

  13 min read
• Biotech Beach

  Company Profile for Invitrogen Corporation

  December 21, 2007

   · 

  1 min read
• Biotech Beach

  Invitrogen Corporation to Present at 26th Annual JP Morgan Healthcare Conference

  December 21, 2007

   · 

  1 min read
• Drug Development

  Biovest International, Inc. Reaffirms Its Confidence in the Ongoing Unblinding of the BiovaxID(TM) Phase 3 Data Based on a Track Record of Eliciting an Immune Response in 80% of Patients

  December 21, 2007

   · 

  1 min read
• Drug Development

  Accentia Biopharmaceuticals Reaffirms its Confidence in the Ongoing Unblinding of the BiovaxID(TM) Phase 3 Data Based on a Track Record of Eliciting an Immune Response in 80% of Patients

  December 21, 2007

   · 

  1 min read
• Policy

  Basilea Pharmaceutica Announces Filing of New Drug Submission in Canada for Alitretinoin

  December 21, 2007

   · 

  1 min read
• Drug Development

  Aeras Global TB Vaccine Foundation and Crucell N.V. Announce Start of a Tuberculosis Vaccine Clinical Trial in the United States. Aeras Global TB Vaccine Foundation Commits a Further USD 5M to the Development of the Tuberculosis Vaccine

  December 21, 2007

   · 

  1 min read